PL3790984T3 - Sposoby wczesnego przewidywania, monitorowania odpowiedzi na leczenie, nawrotu i prognozowania raka piersi - Google Patents

Sposoby wczesnego przewidywania, monitorowania odpowiedzi na leczenie, nawrotu i prognozowania raka piersi

Info

Publication number
PL3790984T3
PL3790984T3 PL19799344.7T PL19799344T PL3790984T3 PL 3790984 T3 PL3790984 T3 PL 3790984T3 PL 19799344 T PL19799344 T PL 19799344T PL 3790984 T3 PL3790984 T3 PL 3790984T3
Authority
PL
Poland
Prior art keywords
recurrence
methods
breast cancer
treatment response
early prediction
Prior art date
Application number
PL19799344.7T
Other languages
English (en)
Inventor
Ruo-kai LIN
Chin-sheng HUNG
Sheng-chao WANG
Yu-Mei CHUNG
Chih-Ming Su
Original Assignee
EG BioMed Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EG BioMed Co., Ltd. filed Critical EG BioMed Co., Ltd.
Publication of PL3790984T3 publication Critical patent/PL3790984T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PL19799344.7T 2018-05-08 2019-05-08 Sposoby wczesnego przewidywania, monitorowania odpowiedzi na leczenie, nawrotu i prognozowania raka piersi PL3790984T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862668435P 2018-05-08 2018-05-08
PCT/US2019/031292 WO2019217537A1 (en) 2018-05-08 2019-05-08 Methods for early prediction, treatment response, recurrence and prognosis monitoring of breast cancer

Publications (1)

Publication Number Publication Date
PL3790984T3 true PL3790984T3 (pl) 2024-04-02

Family

ID=68468332

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19799344.7T PL3790984T3 (pl) 2018-05-08 2019-05-08 Sposoby wczesnego przewidywania, monitorowania odpowiedzi na leczenie, nawrotu i prognozowania raka piersi

Country Status (12)

Country Link
US (1) US12203140B2 (pl)
EP (1) EP3790984B1 (pl)
JP (2) JP7649437B2 (pl)
KR (1) KR102897529B1 (pl)
CN (1) CN112534069B (pl)
AU (1) AU2019265619B2 (pl)
ES (1) ES2968487T3 (pl)
MY (1) MY204233A (pl)
PL (1) PL3790984T3 (pl)
SG (1) SG11202011007UA (pl)
TW (1) TWI721414B (pl)
WO (1) WO2019217537A1 (pl)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7820386B2 (en) 2007-06-15 2010-10-26 National Defense Medical Center Cancer screening method
WO2012031008A2 (en) * 2010-08-31 2012-03-08 The General Hospital Corporation Cancer-related biological materials in microvesicles
US20140113286A1 (en) 2010-12-21 2014-04-24 Sloan-Kettering Institute For Cancer Research Epigenomic Markers of Cancer Metastasis
US20130296328A1 (en) * 2011-01-20 2013-11-07 Université Libre de Bruxelles Epigenetic portraits of human breast cancers
EP2828405B1 (en) 2012-03-20 2017-06-28 Exact Sciences Corporation Marker panel for detecting cancer
EP3194624B1 (en) * 2014-09-15 2022-02-16 Garvan Institute of Medical Research Methods for diagnosis, prognosis and monitoring of breast cancer and reagents therefor
US20180298447A1 (en) 2014-11-07 2018-10-18 Rheinisch Friedrich-Wilhelms-Universität Bonn Institut Für Rekonstruktive Neurobiologie Methods for assessing the treatment response of cancer patients and for treating cancer patients by analysing cpg methylation
WO2017119510A1 (ja) * 2016-01-08 2017-07-13 国立大学法人京都大学 乳がんの診断のための検査方法、遺伝子マーカー、および検査薬
US10058293B2 (en) * 2016-02-19 2018-08-28 Morpho Detection, Llc Detector assemblies and methods for helical CT scanning
WO2017201606A1 (en) * 2016-05-04 2017-11-30 Queen's University At Kingston Cell-free detection of methylated tumour dna
JP7277460B2 (ja) 2017-11-30 2023-05-19 マヨ ファウンデーション フォア メディカル エデュケーション アンド リサーチ 乳癌の検出

Also Published As

Publication number Publication date
CN112534069B (zh) 2024-09-06
JP7649437B2 (ja) 2025-03-21
SG11202011007UA (en) 2020-12-30
ES2968487T3 (es) 2024-05-09
CN112534069A (zh) 2021-03-19
EP3790984C0 (en) 2023-11-22
US20210189500A1 (en) 2021-06-24
EP3790984A4 (en) 2022-03-09
KR20210042263A (ko) 2021-04-19
AU2019265619A1 (en) 2020-12-03
JP2021522814A (ja) 2021-09-02
EP3790984B1 (en) 2023-11-22
MY204233A (en) 2024-08-16
US12203140B2 (en) 2025-01-21
TW202006142A (zh) 2020-02-01
KR102897529B1 (ko) 2025-12-08
WO2019217537A1 (en) 2019-11-14
JP2024061799A (ja) 2024-05-08
TWI721414B (zh) 2021-03-11
EP3790984A1 (en) 2021-03-17
AU2019265619B2 (en) 2025-05-08

Similar Documents

Publication Publication Date Title
SG11202106130UA (en) Transcriptomic profiling for prognosis of breast cancer
SG11202004159WA (en) Machine learning-based method for prediction of breast cancer prognosis using next-generation sequencing, and prediction system therefor
IL268524A (en) Immunological biomarker for predicting clinical outcome of cancer immunotherapy
EP3194624A4 (en) Methods for diagnosis, prognosis and monitoring of breast cancer and reagents therefor
IL280760A (en) Pharma
EP3622071A4 (en) CIRCULATING RNA FOR DETECTING, PREDICTING AND MONITORING CANCER
SG11202106398WA (en) Methods and genomic classifiers for prognosis of breast cancer and predicting benefit from adjuvant radiotherapy
MX2017007707A (es) Metodo para predecir respuesta a agentes terapeuticos de cancer de mama y metodo de tratamiento de cancer de mama.
EP3245302B8 (en) Mirna-based predictive models for diagnosis and prognosis of prostate cancer
SG11202006974WA (en) Methods for colon cancer detection and treatment monitoring
IL268235A (en) Improved methods for assessing risk of developing breast cancer
IL288970A (en) Methods for detecting and predicting breast cancer
IL276748A (en) Methods for the detection and treatment of prostate cancer
SG11201508544VA (en) Genetic marker for early breast cancer prognosis prediction and diagnosis, and use thereof
IL273844A (en) Methods for assessing the risk of developing breast cancer
MA40636A (fr) Procédés pour détecter le cancer de la prostate
EP3606536A4 (en) INDICATIVE BIOMARKERS OF PROSTATE CANCER AND RELATED TREATMENT
GB201619808D0 (en) Biomarkers for the prognosis and diagnosis of cancer
IL286255A (en) Improved method for the screening, diagnosis and/or monitoring of colorectal advanced neoplasia, advanced adenoma and/or colorectal cancer
SG11202011007UA (en) Methods for early prediction, treatment response, recurrence and prognosis monitoring of breast cancer
GB201919174D0 (en) Determining risk of cancer recurrence
GB201910444D0 (en) Methods of diagnosing cancer
EP3189161A4 (en) Methods for diagnosis, prognosis and methods of treatment
GB201617722D0 (en) Method for determining prognosis of cancer
IL268274A (en) Methods for diagnosing malignant diseases